Synthesis and evaluation of new β-carboline-3-(4-benzylidene)- 4H-oxazol-5-one derivatives as antitumor agents

Molecules

Volumn 17, Issue 5, 2012, Pages 6100-6113

  Savariz, Franciele Cristina ^a   Foglio, Mary Ann ^b   De Carvalho, Joao Ernesto ^b   Ruiz, Ana Lúcia T G ^b   Duarte, Marta C T ^b   Da Rosa, Mauricio Ferreira ^c   Meyer, Emerson ^a   Sarragiotto, Maria Helena ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

Author keywords

carboline; 4H oxazol 5 one; Antimicrobial activity; Cytotoxic activity

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BETA CARBOLINE 3 (4 BENZYLIDENE) 4H OXAZOL 5 ONE; BETA-CARBOLINE-3-(4-BENZYLIDENE)-4H-OXAZOL-5-ONE; CARBOLINE DERIVATIVE; OXAZOLE DERIVATIVE;

ARTICLE; BACTERIUM; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; FUNGUS; HUMAN; IC 50; SYNTHESIS; TUMOR CELL LINE;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; CARBOLINES; CELL LINE, TUMOR; CELL SURVIVAL; FUNGI; HUMANS; INHIBITORY CONCENTRATION 50; OXAZOLES;

EID: 84861489570     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17056100     Document Type: Article

References (39)

1. Cao, R.; Peng, W.; Wang, Z.; Xu, A. b-Carboline alkaloids: Biochemical and pharmacological functions. Curr. Med. Chem. 2007, 14, 479-500.
2. Yao, K.; Zhao, M.; Zhang, X.; Wang, Y.; Li, L.; Zheng, M.; Peng, S. A class of oral N-[(1S,3S)-1- methyl-1,2,3,4-tetrahydro-β-carboline-3- carbonyl]-N-(amino-acid-acyl) hydrazine: Discovery, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysis. Eur. J. Med. Chem. 2011, 46, 3237-3249.
3. Bi, W.; Bi, Y.; Xue, P.; Zhang, Y.; Gao, X.; Wang, Z.; Li, M.; Baudy-Floc'h, M.; Ngerebara, N.; Gibson, M.K.; et al. A new class of β-carboline alkaloid-peptide conjugates with therapeutic efficacy in acute limb ischemia/reperfusion injury. Eur. J. Med. Chem. 2011, 46, 1453-1462.
4. Liu, J.; Jiang, X.; Zhao, M.; Zhang, X.; Zheng, M.; Peng, L.; Peng, S. A class of 3S-2- aminoacyltetrahydro-b-carboline-3-carboxylic acids: Their facile synthesis, inhibition for platelet activation, and high in vivo anti-thrombotic potency. J. Med. Chem. 2010, 53, 3106-3116.
5. Costa, E.V.; Pinheiro, M.L.B.; de Souza, A.D.L.; Barison, A.; Campos, F.R.; Valdez, R.H.; Ueda-Nakamura, T.; Dias, B.P.; Nakamura, C.V. Trypanocidal activity of oxoaporphine and pyrimidine-b-carboline alkaloids from the branches of Annona foetida Mart. (Annonaceae). Molecules 2011, 16, 9714-9720.
6. Polanski, W.; Reichmann, H.; Gille, G. Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-b-carboline: A new anti-Parkinson drug? Expert Rev. Neurother. 2011, 11, 845-860.
7. Valdez, R.H.; Tonin, L.T.D.; Ueda-Nakamura, T.; Silva, S.O.; Dias, B.P.; Kaneshima, E.N.; Yamada-Ogatta, S.F.; Yamauchi, L.M.; Sarragiotto, M.H.; Nakamura, C.V. In vitro and in vivo trypanocidal synergistic activity of N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-b- carboline-3-carboxamide) associated with benznidazole. Antimicrob. Agents Chemother. 2012, 56, 507-512.
8. Ikeda, R.; Kurosawa, M.; Okabayashi, T.; Takei, A.; Yoshiwara, M.; Kumakura, T.; Sakai, N.; Funatsu, O.; Morita, A.; Ikekita, M.; et al. 3-(3-phenoxybenzyl)amino-b-carboline: A novel antitumor drug targeting a-tubulin. Bioorg. Med. Chem. Lett. 2011, 21, 4784-4787.
9. Shen, L.; Park, E.-J.; Kondratyuk, P.; Guendisch, D.; Marler, L.; Pezzuto, J.M.; Wright, A.D.; Sun, D. Design, synthesis, and biological evaluation of callophycin A and analogues as potential chemopreventive and anticancer agents. Bioorg. Med. Chem. 2011, 19, 6182-6195.
10. Chen, Z.; Cao, R.; Shi, B.; Guo, L.; Sun, J.; Ma, Q.; Fan, W.; Song, H. Synthesis and biological evaluation of 1,9-disubstituted b-carbolines as potent DNA intercalating and cytotoxic agents. Eur. J. Med. Chem. 2011, 46, 5127-5137.
11. Zhang, X.; Yang, Y.; Zhao, M.; Liu, L.; Zheng, M.; Wang, Y.; Wu, J.; Peng, S. A class of Trp-Trp-AA-OBzl: Synthesis, in vitro anti-proliferation/in vivo anti-tumor evaluation, intercalationmechanism investigation and 3D QSAR analysis. Eur. J. Med. Chem. 2011, 46, 3410-3419.
12. Chen, Z.; Cao, R.; Shi, B.; Yi, W.; Yu, L.; Song, H.; Ren, Z. Synthesis and biological evaluation of novel b-carbolines as potent cytotoxic and DNA intercalating agents. Chem. Pharm. Bull. 2010, 58, 901-907.
13. Ma, C.; Cao, R.; Shi, B.; Zhou, X.; Ma, Q.; Sun, J.; Guo, L.; Yi, W.; Chen, Z.; Song, H. Synthesis and cytotoxic evaluation of 1-carboxamide and 1-amino side chain substituted b-carbolines. Eur. J. Med. Chem. 2010, 45, 5513-5519.
14. Chen, Z.; Cao, R.; Yu, L.; Shi, B.; Sun, J.; Guo, L.; Ma, Q.; Yi, W.; Song, X.; Song, H. Synthesis, cytotoxic activities and DNA binding properties of b-carboline derivatives. Eur. J. Med. Chem. 2010, 45, 4740-4745.
15. Cao, R.; Guan, X.; Shi, B.; Chen, Z.; Ren, Z.; Peng, W.; Song, H. Design, synthesis and 3D-QSAR of b-carboline derivatives as potent antitumor agents. Eur. J. Med. Chem. 2010, 45, 2503-2515.
16. Wu, J.; Li, C.; Zhao, M.; Wang, W.; Wang, Y.; Peng, S. A class of novel carboline intercalators: Their synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and 3D QSAR analysis. Bioorg. Med. Chem. 2010, 18, 6220-6229.
17. Formagio, A.S.N.; Tonin, L.T.D.; Foglio, M.A.; Madjarof, C.; de Carvalho, J.E.; da Costa, W.F.; Cardoso, F.P.; Sarragiotto, M.H. Synthesis and antitumoral activity of novel 3-(2-substituted- 1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) b-carboline derivatives. Bioorg. Med. Chem. 2008, 16, 9660-9667.
18. Savariz, F.C.; Formagio, A.S.N.; Barbosa, V.A.; Foglio, M.A.; de Carvalho, J.E.; Duarte, M.C.T.; Filho, B.P.D.; Sarragiotto, M.H. Synthesis, antitumor and antimicrobial activity of novel 1-substituted phenyl-3-[3- alkylamino(methyl)-2-thioxo-1,3,4-oxadiazol-5-yl] b-carboline derivatives. J. Braz. Chem. Soc. 2010, 21, 288-298.
19. Barbosa, V.A.; Formagio, A.S.N.; Savariz, F.C.; Foglio, M.A.; Spindola, H.M.; de Carvalho, J.E.; Meyer, E.; Sarragiotto, M.H. Synthesis and antitumor activity of b-carboline 3-(substitutedcarbohydrazide) derivatives. Bioorg. Med. Chem. 2011, 19, 6400-6408.
20. Wu, S.; Fu, Y.; Yan, R.; Wu, Y.; Lei, X.; Ye, S. Synthesis of neamine-carboline conjugates for RNA binding and their antibacterial activities. Tetrahedron 2010, 66, 3433-3440.
21. Schupp, P.; Poehner, T.; Edrada, R.; Ebel, R.; Berg, A.; Wray, V.; Proksch, P. Eudistomins W and X, two new b-carbolines from the Micronesian Tunicate Eudistoma sp. J. Nat. Prod. 2003, 66, 272-275.
22. Desai, N.C.; Bhavsar, A.M.; Baldaniya, B.B. Synthesis and antimicrobial activity of 5-imidazolinone derivatives. Indian J. Pharm. Sci. 2009, 71, 90-94.
23. Argade, N.D.; Kalrale, B.K.; Gill, C.H. Microwave assisted improved method for the synthesis of pyrazole containing 2,4,-disubstitute oxazole-5-one and their antimicrobial activity. Eur. J. Chem. 2008, 5, 120-129.
24. Salgin-Goken, U.; Gokhan-Kelekçi, N.; Goktas, O.; Koysal, Y.; Kilic, E.; Isik, S.; Aktay, G.; Ozalp, M. 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: Synthesis, analgesic, anti-inflammatory and antimicrobial activities. Bioorg. Med. Chem. 2007, 15, 5738-5751.
25. Siddiqui, I.R.; Singh, P.K.; Srivastava, V.; Singh, J. Facile synthesis of acyclic analogues of carbocyclic nucleoside as potential anti-HIV pro-drug. Indian J. Chem. 2010, 49B, 512-520.
26. Perron-Sierra, F.M.; Pierré, A.; Burbridge, M.; Guilbaud, N.; Novel bicyclic oxazolone derivatives as anti-angiogenic agents. Bioorg. Med. Chem. Lett. 2002, 12, 1463-1466.
27. Khan, K.M.; Mughal, U.R.; Khan, M.T.H.; Zia-Ullah; Perveen, S.; Choudhary, M.I. Oxazolones: New tyrosinase inhibitors; synthesis and their structure-activity relationships. Bioorg. Med. Chem. 2006, 14, 6027-6033.
28. Mesaik, M.A.; Rahat, S.; Khan, K.M.; Zia-Ullah; Choudhary, M.I.; Murad, S.; Ismail, Z.; Atta-ur-Rahman; Ahmad, A. Synthesis and immunomodulatory properties of selected oxazolone derivatives. Bioorg. Med. Chem. 2004, 12, 2049-2057.
29. Bala, S.; Saini, M.; Kamboj, S. Methods for synthesis of Oxazolones: A Review. Int. J. ChemTech Res. 2011, 3, 1102-1118.
30. Tikdari, A.M.; Fozooni, S.; Hamidian, H. Dodecatungstophosphoric acid (H3PW12O40), samarium and ruthenium (III) chloride catalyzed synthesis of unsaturated 2-phenyl-5(4H)-oxazolone derivatives under solvent-free conditions. Molecules 2008, 13, 3246-3252.
31. Cleary, T.; Rawalpally, T.; Kennedy, N.; Chavez, F. Catalyzing the Erlenmeyer Plöchl reaction: Organic bases versus sodium acetate. Tetrahedron Lett. 2010, 51, 1533-1536.
32. Ma, C.; Cao, R.; Shi, B.; Li, S.; Chen, Z.; Yi, W.; Peng, W.; Ren, Z.; Song, H. Synthesis and cytotoxic evaluation of N2-benzylated quaternary b-carboline amino acid ester conjugates. Eur. J. Med. Chem. 2010, 45, 1515-1523.
33. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997, 23, 3-25.
34. Ertl, P. Calculation of Molecular Properties and Bioactivity Score. Available online: http://www.molinspiration.com (accessed on 31 January 2012
35. Sander, T. Molecular Property Explorer. Available online: http://www.organic-chemistry.org/ prog/peo (accessed on 31 January 2012
36. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 1991, 83, 757-766.
37. Shoemaker, R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 2006, 6, 813-823.
38. NCCLS. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Approved Standard, 6th Ed.; NCCLS document M7-A6; NCCLS: Wayne, MI, USA, 2003.
39. NCCLS. Methods for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard, 2nd Ed.; NCCLS document M27-A; NCCLS: Wayne, MI, USA, 2002.